Journal of Commercial Biotechnology

Exciting changes
pp. 289-289(1)
Author: Friedman, Yali

New technologies for neglected diseases: Can tax credits help biotechnology companies advance global health?
pp. 290-292(3)
Author: Rao, Aarthi

Biotechnology commercialisation in universities of developing countries: A review of the University of Ibadan, Nigeria
pp. 293-300(8)
Author: Onyeka, Chimdiya Julian

Innovation in R&D: Using design thinking to develop new models of inventiveness, productivity and collaboration
pp. 301-307(7)
Authors: Simons, Tad; Gupta, Arvind; Buchanan, Mary

The strength of pharmaceutical IPRs vis-à-vis foreign direct investment in clinical research: Preliminary findings
pp. 308-318(11)
Authors: Pugatch, Meir Perez; Chu, Rachel

Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
pp. 319-329(11)
Authors: Sandle, Tim; Saghee, Madhu Raju

Catalyzing capital for Canada's life sciences industry
pp. 330-348(19)
Authors: Tucker, Joseph; Chakma, Justin; Fedak, Paul WM; Cimini, Massimo

Academic entrepreneurship, entrepreneurial universities and biotechnology
pp. 349-357(9)
Authors: Meyers, Arlen D; Pruthi, Sarika

Patent strategies for life sciences companies to navigate the changing patent landscape
pp. 358-364(7)
Authors: Dykeman, David J; Abramson, Danielle T

FDA at BIO 2011 - Weighing a hefty mission: Where is the balance?
pp. 365-366(2)
Author: Levy, Suzanne